174 related articles for article (PubMed ID: 18311149)
21. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
Groot F; van Capel TM; Schuitemaker J; Berkhout B; de Jong EC
Retrovirology; 2006 Aug; 3():52. PubMed ID: 16916447
[TBL] [Abstract][Full Text] [Related]
22. A reservoir for HIV in patients on combination antiretroviral therapy.
Siliciano RF
Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
[TBL] [Abstract][Full Text] [Related]
23. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
Haase AT
Annu Rev Immunol; 1999; 17():625-56. PubMed ID: 10358770
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV.
Chomont N; DaFonseca S; Vandergeeten C; Ancuta P; Sékaly RP
Curr Opin HIV AIDS; 2011 Jan; 6(1):30-6. PubMed ID: 21242891
[TBL] [Abstract][Full Text] [Related]
25. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
[TBL] [Abstract][Full Text] [Related]
26. Latency: the hidden HIV-1 challenge.
Marcello A
Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 and immune control: can we change the course of HIV-1?
Kovacs A; Connors M
Lancet; 2004 Mar; 363(9412):833-4. PubMed ID: 15031022
[No Abstract] [Full Text] [Related]
28. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
[TBL] [Abstract][Full Text] [Related]
29. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.
Mehandru S; Poles MA; Tenner-Racz K; Manuelli V; Jean-Pierre P; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
J Virol; 2007 Jan; 81(2):599-612. PubMed ID: 17065209
[TBL] [Abstract][Full Text] [Related]
31. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
[TBL] [Abstract][Full Text] [Related]
32. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
Lepej SZ; Begovac J; Vince A
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid-induced apoptosis requires FOXO3A activity.
Ma J; Xie Y; Shi Y; Qin W; Zhao B; Jin Y
Biochem Biophys Res Commun; 2008 Dec; 377(3):894-8. PubMed ID: 18957280
[TBL] [Abstract][Full Text] [Related]
34. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
35. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
Jesser RD; Li S; Weinberg A
Virology; 2006 Sep; 352(2):408-17. PubMed ID: 16782163
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.
Gea-Banacloche JC; Martino L; Mican JM; Hallahan CW; Baseler M; Stevens R; Lambert L; Polis M; Lane HC; Connors M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1877-86. PubMed ID: 11118073
[TBL] [Abstract][Full Text] [Related]
37. Latently infected cell activation: a way to reduce the size of the HIV reservoir?
Forde J; Volpe JM; Ciupe SM
Bull Math Biol; 2012 Jul; 74(7):1651-72. PubMed ID: 22562387
[TBL] [Abstract][Full Text] [Related]
38. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.
Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM
Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071
[TBL] [Abstract][Full Text] [Related]
39. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection.
van Grevenynghe J; Halwani R; Chomont N; Ancuta P; Peretz Y; Tanel A; Procopio FA; shi Y; Said EA; Haddad EK; Sekaly RP
Semin Immunol; 2008 Jun; 20(3):196-203. PubMed ID: 18757210
[TBL] [Abstract][Full Text] [Related]
40. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
Benito JM; López M; Martín JC; Lozano S; Martínez P; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1379-88. PubMed ID: 12487809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
